Ocugen, Inc. Announces Adjournment of Annual Meeting of Shareholders
MALVERN, Pa., June 09, 2023 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today... | June 9, 2023